These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

888 related items for PubMed ID: 27926504

  • 1. The immunomodulatory effects of TNF-α inhibitors on human Th17 cells via RORγt histone acetylation.
    Lin YC, Lin YC, Wu CC, Huang MY, Tsai WC, Hung CH, Kuo PL.
    Oncotarget; 2017 Jan 31; 8(5):7559-7571. PubMed ID: 27926504
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor-alpha inhibitors suppress CCL2 chemokine in monocytes via epigenetic modification.
    Lin YC, Lin YC, Huang MY, Kuo PL, Wu CC, Lee MS, Hsieh CC, Kuo HF, Kuo CH, Tsai WC, Hung CH.
    Mol Immunol; 2017 Mar 31; 83():82-91. PubMed ID: 28113136
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Down-regulation of the Th1, Th17, and Th22 pathways due to anti-TNF-α treatment in psoriasis.
    Luan L, Han S, Wang H, Liu X.
    Int Immunopharmacol; 2015 Dec 31; 29(2):278-284. PubMed ID: 26585971
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy.
    Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL.
    Arthritis Res Ther; 2011 Jul 30; 13(4):R126. PubMed ID: 21801431
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis.
    Hull DN, Williams RO, Pathan E, Alzabin S, Abraham S, Taylor PC.
    Clin Exp Immunol; 2015 Sep 30; 181(3):401-6. PubMed ID: 25766640
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Interleukin-23 drives expansion of Thelper 17 cells through epigenetic regulation by signal transducer and activators of transcription 3 in lupus patients.
    Lee S, Nakayamada S, Kubo S, Yamagata K, Yoshinari H, Tanaka Y.
    Rheumatology (Oxford); 2020 Oct 01; 59(10):3058-3069. PubMed ID: 32375179
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of Cryptotanshinone on experimental rheumatoid arthritis through downregulating p300 mediated-STAT3 acetylation.
    Wang Y, Zhou C, Gao H, Li C, Li D, Liu P, Huang M, Shen X, Liu L.
    Biochem Pharmacol; 2017 Aug 15; 138():119-129. PubMed ID: 28522406
    [Abstract] [Full Text] [Related]

  • 18. The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients.
    Yue C, You X, Zhao L, Wang H, Tang F, Zhang F, Zhang X, He W.
    Rheumatol Int; 2010 Nov 15; 30(12):1553-7. PubMed ID: 19847432
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.